Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug. The article is published in Science Signaling.
Apr 10, 2025
0
65









